期刊： BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (1)
期刊： BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (1)
Autologous stem cell transplant (ASCT) is the standard of care for patients with multiple myeloma (MM). The clinical significance of peripheral blood ......
期刊： BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (2)
Basiliximab has been used successfully as a second-line treatment for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) in adult patient......
期刊： BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (2)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for patients with myelodysplastic syndromes (MDS) a......
期刊： BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (2)
Although thymus-independent donor-derived T cell expansion may determine the occurrence of graft-versus-host disease (GVHD) and relapse after transpla......
期刊： BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (12)
The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and develo......
期刊： BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (5)
Graft-versus-host disease (GVHD) is a common complication of allogeneic stem cell transplantation (allo-SCT) that carries a high mortality. Although c......
期刊： BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (5)
The incidence of hepatitis B virus (HBV) infection is high in the Asian population. Increasing attention is being given to the risk of HBV reactivatio......
